Bio

Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company changing the way the world treats weight with a new standard of care for obesity treatment. Calibrate has raised more than $125 million from leading investors, including Founders Fund, Tiger Global, Optum Ventures, Forerunner Ventures, Threshold Ventures, and Redesign Health, and was recognized as a World Economic Forum Technology Pioneer in 2021 and by Fast Company’s World Changing Ideas, TIME's Best Inventions, and the Employer Health Innovation Roundtable Traction Awards in 2022. Prior to Calibrate, Isabelle led business operations, growth, and strategic partnerships & communications at Capsule, a technology business rebuilding the pharmacy from the inside out. Before Capsule, she worked at beloved consumer brands in London and New York. Isabelle began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania. She was selected to the Forbes 30 Under 30 list in 2015. Isabelle additionally serves as the Advocacy Chair for Success Academy Charter School’s Young Professionals Committee.